Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1998-03-01

• Fields of study

  Medicine, Economics, Psychology

• Identifiers
  PMID 9559755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Views from funding agencies. Agency for Health Care Policy and Research.

  1998cited by this paper
• Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.

  1996cited by this paper
• Health care costs associated with depressive and anxiety disorders in primary care.

  1995cited by this paper
• Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization

  1995cited by this paper
• How can care for depression become more cost-effective?

  1995cited by this paper
• Collaborative management to achieve treatment guidelines. Impact on depression in primary care.

  1995cited by this paper
• Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression

  1995cited by this paper
• Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs.

  1995cited by this paper
• Methods of pharmacoeconomic evaluation of new medical treatments in psychiatry.

  1995cited by this paper
• Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates

  1994cited by this paper
• Striking a balance between safety and efficacy: experience with the SSRI sertraline

  1994cited by this paper
• Evolutionary trends in the pharmacotherapeutic management of depression.

  1994cited by this paper
• Comparative Tolerability Profiles of the Newer versus Older Antidepressants

  1994cited by this paper
• Contemporary management of depression.

  1994cited by this paper
• Reducing the economic burden of depression

  1994cited by this paper
• What Price Depression?

  1994cited by this paper
• The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey.

  1994cited by this paper
• The economic impact of depression in a workplace.

  1994cited by this paper
• Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization.

  1994cited by this paper
• Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.

  1993cited by this paper
• The economic burden of depression in 1990.

  1993cited by this paper
• The comparative pharmacology of new antidepressants.

  1993cited by this paper
• Service utilization and social morbidity associated with depressive symptoms in the community.

  1992cited by this paper
• The safety profile of paroxetine.

  1992cited by this paper
• Caring for depression in America: lessons learned from early findings of the medical outcomes study.

  1991cited by this paper
• The economic burden of depression.

  1986cited by this paper
• The ecology of medical care.

  1961cited by this paper

• Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia

  2015cites this paper
• Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder

  2015cites this paper
• Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States

  2012cites this paper
• Effects of Testosterone Replacement in Middle-Aged Men With Dysthymia: A Randomized, Placebo-Controlled Clinical Trial

  2009cites this paper
• An Open-Label Pilot Study to Evaluate the Efficacy of Sildenafil Citrate in Middle-Aged Men With Late-Onset Dysthymia

  2008cites this paper
• Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

  2008cites this paper
• Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overview

  2008cites this paper
• Inhibition of the Cardiac L-Type Calcium Channel Current by Antidepressant Drugs

  2008cites this paper
• JQ Bostic et a 1 ANTIDEPRESSANT TREATMENTS ANTIDEPRESSANTS

  2007cites this paper
• KAPITEL 8 – Chronische und therapieresistente Depressionen (ICD-10 F3)

  2006cites this paper
• COST-EFECTIVITAT DEL TRACTAMENT ANTIDEPRESSIU

  2006cites this paper
• Does the use of SSRIs reduce medical care utilization and expenditures?

  2005cites this paper
• Langdurig gebruik van antidepressiva in Nederland in 1991-2001: prevalentie, incidentie en risico-indicatoren*

  2005cites this paper
• Reductions in HIV Risk Behaviors Among Depressed Drug Injectors

  2005cites this paper
• Costs of antidepressant medications associated with inadequate treatment.

  2004cites this paper
• Incidence and determinants of long-term use of antidepressants

  2004cites this paper
• Use of Antidepressant Medications: Are There Differences in Psychiatric Visits Among Patient Treatments in the Veterans Administration?

  2004cites this paper
• Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle

  2003cites this paper
• Economic Evaluation of Antidepressive Agents: A Systematic Critique of Experimental and Observational Studies

  2003cites this paper
• Quantitative analysis of sponsorship bias in economic studies of antidepressants

  2003cites this paper
• The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

  2003cites this paper
• Quantitative analysis of sponsorship bias in economic studies of antidepressants.

  2003cites this paper
• Farmaco-epidemiologisch onderzoek in de psychiatrie

  2002cites this paper
• 39 THE ROLE OF PHARMACEUTICALS IN MENTAL HEALTH CARE OUTCOMES

  2002cites this paper
• Clinically significant non-major depression: old concepts, new insights.

  2002cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression

  2002cites this paper
• 78 COST-EFFECTIVENESS OF THE NEWER GENERATION OF ANTIDEPRESSANTS

  2002cites this paper
• The Effects of Lithium, Valproic Acid, and Carbamazepine During Pregnancy and Lactation

  2001cites this paper
• The Economics of Selective Serotonin Reuptake Inhibitors In Depression

  2001cites this paper
• Depressive Syndromes in Dementia

  2001cites this paper
• Cost-Benefit Analysis of Newer versus Older Antidepressants

  2001cites this paper
• State-Level Treatment Outcome Studies Using Administrative Databases

  2001cites this paper
• The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs

  2000cites this paper
• Pharmacoeconomic studies of antidepressants: Focus on venlafaxine

  2000cites this paper
• Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the US

  2000cites this paper
• Late‐life chronic depression: a 399‐case study in private practice

  2000cites this paper
• Treatment of depressive illness among children and adolescents in the United States

  2000cites this paper
• Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed data.

  2000cites this paper
• Dysthymic disorder: current status and future directions

  2000cites this paper
• The MacArthur Foundation Depression Education Program for Primary Care Physicians: background and rationale.

  2000cites this paper
• The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.

  1999cites this paper
• Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.

  1999cites this paper
• Antidepressant treatment of juvenile depression.

  1999cites this paper
• [Antidepressant pharmacotherapy: a review of pharmaco-economic research].

  1999cites this paper
• Fluoxetine and dothiepin therapy in primary care and health resource utilization: Evidence from the United Kingdom.

  1999cites this paper
• Fluoxetineic Review of its Use in Depression

  1998cites this paper
• Fluoxetine. A pharmacoeconomic review of its use in depression.

  1998cites this paper
• Changes in the social and health services over the last years have forced doctors to concern themselves with cost benefit calculations and budget forecasting. Cost considera- tions are a (co-) determinant in the choice of antidepressants

  year unknowncites this paper